ESMO 2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ESMO 2023
May 15, 2024, 04:12 |
Blog
Tanja Obradovic: News about effectiveness of PD-1 inhibitors in endometrial cancer continues to paint complex picture
Tanja Obradovic shared on LinkedIn: ''News about effectiveness of PD-1 inhibitors in endometrial cancer continues…
Mar 7, 2024, 18:04 |
Blog
Check out the latest 2 podcasts on lung cancer and psycho-oncological perspective- European School of Oncology
European School of Oncology shared a post on LinkedIn: "Check out the latest 2 podcasts:…
Nov 30, 2023, 16:23 |
Drugs
Mariana Brandao: My comment on the ARTEMIDE-01 phase I trial testing a new bispecific anti-PD-1/anti-TIGIT antibody called Rilvegostomig
Mariana Brandao, a Medical Oncologist at Institut Jules Bordet, recently shared on LinkedIn: "Here's my…
Nov 25, 2023, 17:59 |
Drugs
Andrew Pannu: The ADC space is blowing up
Andrew Pannu posted on LinkedIn: "The ADC space is blowing up: • More than $125B in…
Nov 4, 2023, 00:25 |
Insight
María Natalia Gandur Quiroga: After a successful ESMO 23, ADC continues to shine
María Natalia Gandur Quiroga shared a post on X/Twitter: “After a successful ESMO 23, ADC…
Oct 31, 2023, 16:15 |
Insight
Svetlana Nikic: Congratulations to the scientific committee for an excellent ESMO 2023
Svetlana Nikic, Founder of Precision Oncology Consulting, shared on her LinkedIn: "Congratulations to the scientific committee…
Oct 30, 2023, 07:33 |
Blog
Sebastian Werngreen Nielsen: This weekend I had the privilege of attending the ESMO 2023 conference in Madrid as an invited speaker and poster presenter
Quoting Sebastian Werngreen Nielsen, MD at Rigshospitalet Copenhagen University Hospital, on LinkedIn: "This weekend I…
Oct 29, 2023, 03:16 |
Drugs
Antonio Passaro: I was honored to present in Presidential, the primary results of the global randomized phase 3 study MARIPOSA-2
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "ESMO23 is…
Oct 28, 2023, 15:34 |
Blog
Andreas A. Argyriou: Honoured to be an invited speaker at the Madrid ESMO 2023 and present about chemotherapy-induced central neurotoxicity
Andreas A. Argyriou, Neurology Medical Director at Agios Andreas State General Hospital, shared a post o…
Oct 27, 2023, 04:48 |
Insight
Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901
Sumanta K. Pal, Co-Director of the City of Hope Kidney Cancer Program, posted on Twitter: "Eloquent…
1
2
3
All:
23
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube